NCT01194960 2020-10-19TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)Oxford BioMedicaPhase 2 Terminated25 enrolled
NCT00521274 2016-03-17Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate CancerThe Methodist Hospital Research InstitutePhase 2 Terminated11 enrolled